Department of Radiation Oncology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Ann Med. 2024 Dec;56(1):2282184. doi: 10.1080/07853890.2023.2282184. Epub 2024 May 13.
AURKA is a threonine or serine kinase that needs to be activated by TPX2, Bora and other factors. AURKA is located on chromosome 20 and is amplified or overexpressed in many human cancers, such as breast cancer. AURKA regulates some basic cellular processes, and this regulation is realized the phosphorylation of downstream substrates. AURKA can function in either the cytoplasm or the nucleus. It can promote the transcription and expression of oncogenes together with other transcription factors in the nucleus, including FoxM1, C-Myc, and NF-κB. In addition, it also sustains carcinogenic signaling, such as N-Myc and Wnt signaling. This article will focus on the role of AURKA in the nucleus and its carcinogenic characteristics that are independent of its kinase activity to provide a theoretical explanation for mechanisms of resistance to kinase inhibitors and a reference for future research on targeted inhibitors.
AURKA 是一种苏氨酸或丝氨酸激酶,需要由 TPX2、Bora 和其他因素激活。AURKA 位于染色体 20 上,在许多人类癌症中扩增或过表达,如乳腺癌。AURKA 调节一些基本的细胞过程,这种调节是通过磷酸化下游底物来实现的。AURKA 可以在细胞质或细胞核中发挥作用。它可以与核内其他转录因子(包括 FoxM1、C-Myc 和 NF-κB)一起促进癌基因的转录和表达。此外,它还维持致癌信号,如 N-Myc 和 Wnt 信号。本文将重点介绍 AURKA 在细胞核中的作用及其致癌特性,这些特性与其激酶活性无关,为激酶抑制剂耐药机制提供理论解释,并为靶向抑制剂的未来研究提供参考。